Rapidly progressive infiltrated plaques in a transplant recipient.
Identifieur interne : 000758 ( Main/Exploration ); précédent : 000757; suivant : 000759Rapidly progressive infiltrated plaques in a transplant recipient.
Auteurs : I. Salgüero Fernández [Espagne] ; F. Alfageme Roldán [Espagne] ; D. Suarez Massa [Espagne] ; G. Roustan Gull N [Espagne]Source :
- Actas dermo-sifiliograficas [ 1578-2190 ] ; 2017.
Descripteurs français
- KwdFr :
- Acide mycophénolique (effets indésirables), Acide mycophénolique (usage thérapeutique), Adulte d'âge moyen (MeSH), Anticorps antiviraux (sang), Complications postopératoires (diagnostic), Complications postopératoires (virologie), Complications postopératoires (étiologie), Donneurs de tissus (MeSH), Herpèsvirus humain de type 8 (immunologie), Herpèsvirus humain de type 8 (isolement et purification), Humains (MeSH), Immunosuppresseurs (effets indésirables), Infections à Herpesviridae (transmission), Mâle (MeSH), Sarcome de Kaposi (diagnostic), Sarcome de Kaposi (virologie), Sarcome de Kaposi (étiologie), Substitution de médicament (MeSH), Tacrolimus (effets indésirables), Tacrolimus (usage thérapeutique), Transplantation pulmonaire (effets indésirables), Tumeurs du thorax (diagnostic), Tumeurs du thorax (virologie), Tumeurs du thorax (étiologie), Virémie (diagnostic), Virémie (étiologie), Érythème (étiologie), Évérolimus (usage thérapeutique).
- MESH :
- diagnostic : Complications postopératoires, Sarcome de Kaposi, Tumeurs du thorax, Virémie.
- effets indésirables : Acide mycophénolique, Immunosuppresseurs, Tacrolimus, Transplantation pulmonaire.
- immunologie : Herpèsvirus humain de type 8.
- isolement et purification : Herpèsvirus humain de type 8.
- sang : Anticorps antiviraux.
- usage thérapeutique : Acide mycophénolique, Infections à Herpesviridae, Tacrolimus, Évérolimus.
- virologie : Complications postopératoires, Sarcome de Kaposi, Tumeurs du thorax.
- étiologie : Complications postopératoires, Sarcome de Kaposi, Tumeurs du thorax, Virémie, Érythème.
- Adulte d'âge moyen, Donneurs de tissus, Humains, Mâle, Substitution de médicament.
English descriptors
- KwdEn :
- Antibodies, Viral (blood), Drug Substitution (MeSH), Erythema (etiology), Everolimus (therapeutic use), Herpesviridae Infections (transmission), Herpesvirus 8, Human (immunology), Herpesvirus 8, Human (isolation & purification), Humans (MeSH), Immunosuppressive Agents (adverse effects), Lung Transplantation (adverse effects), Male (MeSH), Middle Aged (MeSH), Mycophenolic Acid (adverse effects), Mycophenolic Acid (therapeutic use), Postoperative Complications (diagnosis), Postoperative Complications (etiology), Postoperative Complications (virology), Sarcoma, Kaposi (diagnosis), Sarcoma, Kaposi (etiology), Sarcoma, Kaposi (virology), Tacrolimus (adverse effects), Tacrolimus (therapeutic use), Thoracic Neoplasms (diagnosis), Thoracic Neoplasms (etiology), Thoracic Neoplasms (virology), Tissue Donors (MeSH), Viremia (diagnosis), Viremia (etiology).
- MESH :
- chemical , adverse effects : Immunosuppressive Agents, Mycophenolic Acid, Tacrolimus.
- chemical , blood : Antibodies, Viral.
- adverse effects : Lung Transplantation.
- diagnosis : Postoperative Complications, Sarcoma, Kaposi, Thoracic Neoplasms, Viremia.
- etiology : Erythema, Postoperative Complications, Sarcoma, Kaposi, Thoracic Neoplasms, Viremia.
- immunology : Herpesvirus 8, Human.
- isolation & purification : Herpesvirus 8, Human.
- chemical , therapeutic use : Everolimus, Mycophenolic Acid, Tacrolimus.
- transmission : Herpesviridae Infections.
- virology : Postoperative Complications, Sarcoma, Kaposi, Thoracic Neoplasms.
- Drug Substitution, Humans, Male, Middle Aged, Tissue Donors.
DOI: 10.1016/j.ad.2016.05.007
PubMed: 27677210
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Rapidly progressive infiltrated plaques in a transplant recipient.</title>
<author><name sortKey="Salguero Fernandez, I" sort="Salguero Fernandez, I" uniqKey="Salguero Fernandez I" first="I" last="Salgüero Fernández">I. Salgüero Fernández</name>
<affiliation wicri:level="3"><nlm:affiliation>Hospital Puerta de Hierro, Majadahonda, Madrid, España. Electronic address: irenebsf@hotmail.com.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital Puerta de Hierro, Majadahonda, Madrid</wicri:regionArea>
<placeName><settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Alfageme Roldan, F" sort="Alfageme Roldan, F" uniqKey="Alfageme Roldan F" first="F" last="Alfageme Roldán">F. Alfageme Roldán</name>
<affiliation wicri:level="3"><nlm:affiliation>Hospital Puerta de Hierro, Majadahonda, Madrid, España.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital Puerta de Hierro, Majadahonda, Madrid</wicri:regionArea>
<placeName><settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Suarez Massa, D" sort="Suarez Massa, D" uniqKey="Suarez Massa D" first="D" last="Suarez Massa">D. Suarez Massa</name>
<affiliation wicri:level="3"><nlm:affiliation>Hospital Puerta de Hierro, Majadahonda, Madrid, España.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital Puerta de Hierro, Majadahonda, Madrid</wicri:regionArea>
<placeName><settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Roustan Gull N, G" sort="Roustan Gull N, G" uniqKey="Roustan Gull N G" first="G" last="Roustan Gull N">G. Roustan Gull N</name>
<affiliation wicri:level="3"><nlm:affiliation>Hospital Puerta de Hierro, Majadahonda, Madrid, España.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital Puerta de Hierro, Majadahonda, Madrid</wicri:regionArea>
<placeName><settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:27677210</idno>
<idno type="pmid">27677210</idno>
<idno type="doi">10.1016/j.ad.2016.05.007</idno>
<idno type="wicri:Area/Main/Corpus">000961</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000961</idno>
<idno type="wicri:Area/Main/Curation">000961</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000961</idno>
<idno type="wicri:Area/Main/Exploration">000961</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Rapidly progressive infiltrated plaques in a transplant recipient.</title>
<author><name sortKey="Salguero Fernandez, I" sort="Salguero Fernandez, I" uniqKey="Salguero Fernandez I" first="I" last="Salgüero Fernández">I. Salgüero Fernández</name>
<affiliation wicri:level="3"><nlm:affiliation>Hospital Puerta de Hierro, Majadahonda, Madrid, España. Electronic address: irenebsf@hotmail.com.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital Puerta de Hierro, Majadahonda, Madrid</wicri:regionArea>
<placeName><settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Alfageme Roldan, F" sort="Alfageme Roldan, F" uniqKey="Alfageme Roldan F" first="F" last="Alfageme Roldán">F. Alfageme Roldán</name>
<affiliation wicri:level="3"><nlm:affiliation>Hospital Puerta de Hierro, Majadahonda, Madrid, España.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital Puerta de Hierro, Majadahonda, Madrid</wicri:regionArea>
<placeName><settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Suarez Massa, D" sort="Suarez Massa, D" uniqKey="Suarez Massa D" first="D" last="Suarez Massa">D. Suarez Massa</name>
<affiliation wicri:level="3"><nlm:affiliation>Hospital Puerta de Hierro, Majadahonda, Madrid, España.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital Puerta de Hierro, Majadahonda, Madrid</wicri:regionArea>
<placeName><settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Roustan Gull N, G" sort="Roustan Gull N, G" uniqKey="Roustan Gull N G" first="G" last="Roustan Gull N">G. Roustan Gull N</name>
<affiliation wicri:level="3"><nlm:affiliation>Hospital Puerta de Hierro, Majadahonda, Madrid, España.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital Puerta de Hierro, Majadahonda, Madrid</wicri:regionArea>
<placeName><settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Actas dermo-sifiliograficas</title>
<idno type="eISSN">1578-2190</idno>
<imprint><date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antibodies, Viral (blood)</term>
<term>Drug Substitution (MeSH)</term>
<term>Erythema (etiology)</term>
<term>Everolimus (therapeutic use)</term>
<term>Herpesviridae Infections (transmission)</term>
<term>Herpesvirus 8, Human (immunology)</term>
<term>Herpesvirus 8, Human (isolation & purification)</term>
<term>Humans (MeSH)</term>
<term>Immunosuppressive Agents (adverse effects)</term>
<term>Lung Transplantation (adverse effects)</term>
<term>Male (MeSH)</term>
<term>Middle Aged (MeSH)</term>
<term>Mycophenolic Acid (adverse effects)</term>
<term>Mycophenolic Acid (therapeutic use)</term>
<term>Postoperative Complications (diagnosis)</term>
<term>Postoperative Complications (etiology)</term>
<term>Postoperative Complications (virology)</term>
<term>Sarcoma, Kaposi (diagnosis)</term>
<term>Sarcoma, Kaposi (etiology)</term>
<term>Sarcoma, Kaposi (virology)</term>
<term>Tacrolimus (adverse effects)</term>
<term>Tacrolimus (therapeutic use)</term>
<term>Thoracic Neoplasms (diagnosis)</term>
<term>Thoracic Neoplasms (etiology)</term>
<term>Thoracic Neoplasms (virology)</term>
<term>Tissue Donors (MeSH)</term>
<term>Viremia (diagnosis)</term>
<term>Viremia (etiology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Acide mycophénolique (effets indésirables)</term>
<term>Acide mycophénolique (usage thérapeutique)</term>
<term>Adulte d'âge moyen (MeSH)</term>
<term>Anticorps antiviraux (sang)</term>
<term>Complications postopératoires (diagnostic)</term>
<term>Complications postopératoires (virologie)</term>
<term>Complications postopératoires (étiologie)</term>
<term>Donneurs de tissus (MeSH)</term>
<term>Herpèsvirus humain de type 8 (immunologie)</term>
<term>Herpèsvirus humain de type 8 (isolement et purification)</term>
<term>Humains (MeSH)</term>
<term>Immunosuppresseurs (effets indésirables)</term>
<term>Infections à Herpesviridae (transmission)</term>
<term>Mâle (MeSH)</term>
<term>Sarcome de Kaposi (diagnostic)</term>
<term>Sarcome de Kaposi (virologie)</term>
<term>Sarcome de Kaposi (étiologie)</term>
<term>Substitution de médicament (MeSH)</term>
<term>Tacrolimus (effets indésirables)</term>
<term>Tacrolimus (usage thérapeutique)</term>
<term>Transplantation pulmonaire (effets indésirables)</term>
<term>Tumeurs du thorax (diagnostic)</term>
<term>Tumeurs du thorax (virologie)</term>
<term>Tumeurs du thorax (étiologie)</term>
<term>Virémie (diagnostic)</term>
<term>Virémie (étiologie)</term>
<term>Érythème (étiologie)</term>
<term>Évérolimus (usage thérapeutique)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Immunosuppressive Agents</term>
<term>Mycophenolic Acid</term>
<term>Tacrolimus</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Antibodies, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Lung Transplantation</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Postoperative Complications</term>
<term>Sarcoma, Kaposi</term>
<term>Thoracic Neoplasms</term>
<term>Viremia</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Complications postopératoires</term>
<term>Sarcome de Kaposi</term>
<term>Tumeurs du thorax</term>
<term>Virémie</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Acide mycophénolique</term>
<term>Immunosuppresseurs</term>
<term>Tacrolimus</term>
<term>Transplantation pulmonaire</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Erythema</term>
<term>Postoperative Complications</term>
<term>Sarcoma, Kaposi</term>
<term>Thoracic Neoplasms</term>
<term>Viremia</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Herpèsvirus humain de type 8</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Herpesvirus 8, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>Herpesvirus 8, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Herpèsvirus humain de type 8</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Anticorps antiviraux</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Everolimus</term>
<term>Mycophenolic Acid</term>
<term>Tacrolimus</term>
</keywords>
<keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>Herpesviridae Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Acide mycophénolique</term>
<term>Infections à Herpesviridae</term>
<term>Tacrolimus</term>
<term>Évérolimus</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Complications postopératoires</term>
<term>Sarcome de Kaposi</term>
<term>Tumeurs du thorax</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Postoperative Complications</term>
<term>Sarcoma, Kaposi</term>
<term>Thoracic Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Complications postopératoires</term>
<term>Sarcome de Kaposi</term>
<term>Tumeurs du thorax</term>
<term>Virémie</term>
<term>Érythème</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Drug Substitution</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Tissue Donors</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Donneurs de tissus</term>
<term>Humains</term>
<term>Mâle</term>
<term>Substitution de médicament</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27677210</PMID>
<DateCompleted><Year>2018</Year>
<Month>06</Month>
<Day>15</Day>
</DateCompleted>
<DateRevised><Year>2018</Year>
<Month>06</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1578-2190</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>108</Volume>
<Issue>3</Issue>
<PubDate><Year>2017</Year>
<Month>04</Month>
</PubDate>
</JournalIssue>
<Title>Actas dermo-sifiliograficas</Title>
<ISOAbbreviation>Actas Dermosifiliogr</ISOAbbreviation>
</Journal>
<ArticleTitle>Rapidly progressive infiltrated plaques in a transplant recipient.</ArticleTitle>
<Pagination><MedlinePgn>255-256</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S0001-7310(16)30168-5</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ad.2016.05.007</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Salgüero Fernández</LastName>
<ForeName>I</ForeName>
<Initials>I</Initials>
<AffiliationInfo><Affiliation>Hospital Puerta de Hierro, Majadahonda, Madrid, España. Electronic address: irenebsf@hotmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>ALfageme Roldán</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
<AffiliationInfo><Affiliation>Hospital Puerta de Hierro, Majadahonda, Madrid, España.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Suarez Massa</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
<AffiliationInfo><Affiliation>Hospital Puerta de Hierro, Majadahonda, Madrid, España.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Roustan Gullón</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
<AffiliationInfo><Affiliation>Hospital Puerta de Hierro, Majadahonda, Madrid, España.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<Language>spa</Language>
<PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Placas infiltradas de rápida evolución en paciente trasplantado.</VernacularTitle>
<ArticleDate DateType="Electronic"><Year>2016</Year>
<Month>09</Month>
<Day>24</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Spain</Country>
<MedlineTA>Actas Dermosifiliogr</MedlineTA>
<NlmUniqueID>0373062</NlmUniqueID>
<ISSNLinking>0001-7310</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007166">Immunosuppressive Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>9HW64Q8G6G</RegistryNumber>
<NameOfSubstance UI="D000068338">Everolimus</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>HU9DX48N0T</RegistryNumber>
<NameOfSubstance UI="D009173">Mycophenolic Acid</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>WM0HAQ4WNM</RegistryNumber>
<NameOfSubstance UI="D016559">Tacrolimus</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D057915" MajorTopicYN="N">Drug Substitution</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004890" MajorTopicYN="N">Erythema</DescriptorName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000068338" MajorTopicYN="N">Everolimus</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006566" MajorTopicYN="N">Herpesviridae Infections</DescriptorName>
<QualifierName UI="Q000635" MajorTopicYN="Y">transmission</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019288" MajorTopicYN="N">Herpesvirus 8, Human</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007166" MajorTopicYN="N">Immunosuppressive Agents</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016040" MajorTopicYN="N">Lung Transplantation</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009173" MajorTopicYN="N">Mycophenolic Acid</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012514" MajorTopicYN="N">Sarcoma, Kaposi</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016559" MajorTopicYN="N">Tacrolimus</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013899" MajorTopicYN="N">Thoracic Neoplasms</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014019" MajorTopicYN="N">Tissue Donors</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014766" MajorTopicYN="N">Viremia</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year>
<Month>04</Month>
<Day>04</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2016</Year>
<Month>05</Month>
<Day>04</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2016</Year>
<Month>05</Month>
<Day>06</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2016</Year>
<Month>9</Month>
<Day>30</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2018</Year>
<Month>6</Month>
<Day>16</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2016</Year>
<Month>9</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">27677210</ArticleId>
<ArticleId IdType="pii">S0001-7310(16)30168-5</ArticleId>
<ArticleId IdType="doi">10.1016/j.ad.2016.05.007</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Espagne</li>
</country>
<region><li>Communauté de Madrid</li>
</region>
<settlement><li>Madrid</li>
</settlement>
</list>
<tree><country name="Espagne"><region name="Communauté de Madrid"><name sortKey="Salguero Fernandez, I" sort="Salguero Fernandez, I" uniqKey="Salguero Fernandez I" first="I" last="Salgüero Fernández">I. Salgüero Fernández</name>
</region>
<name sortKey="Alfageme Roldan, F" sort="Alfageme Roldan, F" uniqKey="Alfageme Roldan F" first="F" last="Alfageme Roldán">F. Alfageme Roldán</name>
<name sortKey="Roustan Gull N, G" sort="Roustan Gull N, G" uniqKey="Roustan Gull N G" first="G" last="Roustan Gull N">G. Roustan Gull N</name>
<name sortKey="Suarez Massa, D" sort="Suarez Massa, D" uniqKey="Suarez Massa D" first="D" last="Suarez Massa">D. Suarez Massa</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Bois/explor/RapamycinFungusV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000758 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000758 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Bois |area= RapamycinFungusV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:27677210 |texte= Rapidly progressive infiltrated plaques in a transplant recipient. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:27677210" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a RapamycinFungusV1
This area was generated with Dilib version V0.6.38. |